Latest market price
32.24
-0.27-0.83%
OverviewShort InterestFilings
SGPQT85SpyGlass Pharma, Inc. Common Stock·NASDAQ
32.24-0.83%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 19, 20268-KCurrent report
Oct 01, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
May 14, 202610-QQuarterly report
May 14, 20268-KCurrent report
Mar 26, 20268-KCurrent report
Mar 26, 202610-KAnnual report
Mar 09, 20268-KCurrent report
Feb 17, 2026SC 13GBeneficial ownership statement (passive)
Feb 17, 2026SC 13DBeneficial ownership statement (active)
Feb 13, 20268-KCurrent report
Feb 13, 2026SC 13GBeneficial ownership statement (passive)
Feb 13, 2026SC 13DBeneficial ownership statement (active)
Feb 13, 2026SC 13DBeneficial ownership statement (active)
Feb 11, 20264Statement of changes in beneficial ownership
Feb 11, 20264Statement of changes in beneficial ownership
Feb 11, 20264Statement of changes in beneficial ownership
Feb 11, 20264Statement of changes in beneficial ownership
Feb 11, 20264Statement of changes in beneficial ownership
Feb 11, 20264Statement of changes in beneficial ownership
Feb 11, 20264Statement of changes in beneficial ownership
Feb 11, 20264Statement of changes in beneficial ownership
Feb 11, 20264Statement of changes in beneficial ownership
Feb 11, 20264/AStatement of changes in beneficial ownership (amended)
#1 / 25 of 90
Page
▼
/ 4